Drug Name and FDA Application Number | Dosage Form/Route | Strength | Marketing Status | Company |
REBETOL
(NDA # 020903)
| CAPSULE; ORAL |
200MG **Indicated for use and comarketed with Interferon ALFA-2B, Recombinant (INTRON A), as Rebetron Combination Therapy** 200MG
|
Prescription
| SCHERING PLOUGH RES |
REBETOL
(NDA # 021546)
| SOLUTION; ORAL |
40MG/ML
|
Prescription
| SCHERING |